Allogeneic astrocytoma in immune competent dogs.
We have induced in canines long-term immune tolerance to an allogeneic cell line derived from a spontaneous canine astrocytoma. Allogeneic astrocytoma cells were implanted endoscopically into the subcutaneous space of fetal dogs before the onset of immune competency (< 40th gestational day). At adulthood, dogs rendered tolerant successfully serve as recipients of intracranial transplants of their growing allogeneic, subcutaneous tumor. Transplanted dogs subsequently develop a solid brain tumor with histological features similar to the original astrocytoma. This model may allow rapid development and evaluation of new therapies for brain tumors, as well as afford tumor biology studies that are untenable in smaller, immune incompetent, or inbred animals harboring less representative tumors.
Berens
M E
ME
Neuro-Oncology Laboratory, Barrow Neurological Institute, Saint Joseph's Hospital and Medical Center, Phoenix, AZ 85013-4496, USA. mberens@chw.edu
Giese
A
A
Shapiro
J R
JR
Coons
S W
SW
D000818:Animals; D001254:Astrocytoma / Q000276:immunology* / Q000473:pathology*; D001932:Brain Neoplasms / Q000276:immunology* / Q000473:pathology*; D004285:Dogs; D008279:Magnetic Resonance Imaging; D009368:Neoplasm Transplantation; D009457:Neuroglia / Q000473:pathology; D014407:Tumor Cells, Cultured